Actively Recruiting

Age: 18Years +
All Genders
ID07006831

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

Led by Devyser Inc. · Updated on 2025-12-17

400

Participants Needed

6

Research Sites

12 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research focuses on kidney transplant patients to collect blood samples and clinical data for developing a non-invasive test that detects donor-derived cell-free DNA (dd-cfDNA) to assess the condition of transplanted kidneys. The study is prospective and multicenter, involving participants who have had a kidney transplant and are undergoing an indication biopsy. The goal is to improve monitoring of the transplanted organ's status. Participants will provide whole blood samples at the time of their indication biopsy, before the biopsy procedure itself. Additionally, leftover de-identified retrospective genomic DNA (gDNA) samples from the kidney donors will be collected for paired analysis. This approach helps researchers study dd-cfDNA in a real-world transplant population. Participants will be involved through blood sample collection and clinical data gathering during their biopsy visits. Researchers will monitor the detection of donor-derived cell-free DNA in whole blood over an 18-month period. The study involves no investigational treatments, focusing on observation and sample analysis. Participation duration and follow-up details align with the biopsy schedule and sample collection requirements.

CONDITIONS

Brief Title

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Willing and able to provide written informed consent
  • Is 18 years of age or older at enrollment
  • Had a kidney transplant prior to enrollment
  • Is having an indication (for cause) biopsy as determined by clinician
  • Retrospective leftover samples are available from the kidney donor(s)
Not Eligible

You will not qualify if you...

  • Is pregnant
  • Had a blood transfusion within the past 4 weeks
  • Had a transplant from an identical (monozygotic) twin
  • Had transplants of multiple organs from the same donor (eg, kidney and liver transplant)
  • Had transplants of more than 2 organs from different donors (eg, recipient of a third kidney transplant)
  • Had a transplant of hematopoietic stem cells (eg, bone marrow) or tissue (eg, heart valve)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - At biopsy time

Participants provide whole blood samples and clinical data at the time of an indication biopsy.

1 visit (in-person)

Long-term Monitoring

Duration - 18 months

Participants' donor-derived cell-free DNA levels are monitored over 18 months.

Trial Site Locations

Total: 6 locations

1

Scripps Health

San Diego, California, United States, 92037

Actively Recruiting

2

University of California San Francisco

San Francisco, California, United States, 94143

Actively Recruiting

3

Piedmont Healthcare

Atlanta, Georgia, United States, 30309

Actively Recruiting

4

University of Maryland Baltimore

Baltimore, Maryland, United States, 21201

Actively Recruiting

5

Brigham & Women's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

6

University of Utah

Salt Lake City, Utah, United States, 84132

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Mixed Cohort, Multicentre Exploratory Study of Non-invasiv...

Kidney Transplant

Actively Recruiting

3 locations

A Phase 1 Study to Evaluate the Pharmacokinetics and Safety ...

Kidney Disease

Actively Recruiting

2 locations

Retrospective Chart Review of Safety Outcomes Associated Wit...

Cytomegalovirus (CMV)

Actively Recruiting

25 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Development and performance of a next generation sequencing (NGS) assay for monitoring of dd-cfDNA post solid organ transplantation.

Linnéa Pettersson, Sofia Westerling, Venkat Talla...

https://pubmed.ncbi.nlm.nih.gov/37951377